BDBM436771 3-Methyl-1-(pyridazin-3-ylmethyl)-6-[5-(trifluoromethyl)-3- thienyl]imidazo[4,5-b]pyridin-2-one::US10617676, Example 103::US11207298, Example 103

SMILES Cc1oc2cc(Oc3ccnn4cc(C(=O)N5C[C@H](F)[C@H]5C)c(C)c34)ccc2c1C(=O)NC1(C)CCC1

InChI Key InChIKey=ODOAOMNGELYMAZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 436771   

TargetVascular endothelial growth factor receptor 2(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 436771BDBM436771(6-({6-[(2R,3S)-3-fluoro-2- methylazetidine-1-carbo...)
Affinity DataEC50:  1.60nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent